Lung Cancer with MET exon 14 Skipping Mutation: Genetic Feature, Current Treatments, and Future Challenges

Lung Cancer with MET exon 14 Skipping Mutation: Genetic Feature, Current Treatments, and Future Challenges

Toshio Fujino, Kenichi Suda, Tetsuya Mitsudomi Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, JapanCorrespondence: Tetsuya MitsudomiKindai University Faculty of Medicine, Division of Thoracic Surgery, Department of Surgery, 377-2 Ohno-Higash...

Full description

Saved in:
Bibliographic Details
Main Authors: Fujino T, Suda K, Mitsudomi T
Format: article
Language:EN
Published: Dove Medical Press 2021
Subjects:
non-small cell lung cancer
met exon 14 skipping
capmatinib
tepotinib
resistance mechanisms
immune checkpoint inhibitors
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Online Access:https://doaj.org/article/f984ebd2259242cf97186c7a243e1fc5
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/f984ebd2259242cf97186c7a243e1fc5

Similar Items